CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE

Abstract

Although poor compliance with recommendations has been reflected in mediocre outcomes, there is evidence that practice is improving.